Louis Frederic Diehl, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
Phone (919) 668-1000
Email address louis.diehl@duke.edu

Research interests include Hodgkin disease, non-Hodgkin lymphomas, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Walter Reed Army Medical Center, 1978 - 1981
  • Medical Resident, Medicine, Walter Reed Army Medical Center, 1975 - 1978
  • M.D., Georgetown University, 1975

Publications

Castro, C. de, D. Adams, D. Rizzieri, J. Moore, J. Gockerman, L. Diehl, M. Horwitz, E. Edmonds, and J. Warzecho. “P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes.” Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). https://doi.org/10.1016/S0145-2126(09)70215-2.

Full Text

Castro, C. de, D. Adams, D. Rizzieri, J. Moore, J. Gockerman, L. Diehl, M. Horwitz, E. Edmonds, and J. Warzecho. “P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes.” Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). https://doi.org/10.1016/S0145-2126(09)70210-3.

Full Text

Weinberg, J. B., A. D. Volkheimer, M. Mihovilovic, N. Jiang, Y. Chen, K. Bond, J. O. Moore, et al. “Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia..” Leukemia 22, no. 12 (December 2008): 2184–92. https://doi.org/10.1038/leu.2008.241.

PMID
18784741
Full Text

Christensen, Dale J., Karen M. Bond, Alicia D. Volkheimer, Jessica Oddo, Youwei Chen, Jon P. Gockerrnan, Joseph O. Moore, et al. “Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity.” Blood 112, no. 11 (November 16, 2008): 140–140.

Scholars@Duke

Gasparet, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos De Castro, Joseph Moore, Gwynn D. Long, Mitchell Horwitz, et al. “Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.” Blood 112, no. 11 (November 16, 2008): 1142–1142.

Scholars@Duke

Weinberg, J Brice, Alicia D. Volkheimer, Youwei Chen, Bethany E. Beasley, Ning Jiang, Mark C. Lanasa, Daphne Friedman, et al. “Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia..” Am J Hematol 82, no. 12 (December 2007): 1063–70. https://doi.org/10.1002/ajh.20987.

PMID
17654680
Full Text

Berdeja, Jesús G., Allan Hess, David M. Lucas, Paul O’Donnell, Richard F. Ambinder, Louis F. Diehl, Denise Carter-Brookins, Susan Newton, and Ian W. Flinn. “Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab..” Clin Cancer Res 13, no. 8 (April 15, 2007): 2392–99. https://doi.org/10.1158/1078-0432.CCR-06-1860.

PMID
17438098
Full Text

Willis, Carl R., Amy Goodrich, Kathy Park, Jamie K. Waselenko, Margaret Lucas, Amy Reese, Louis F. Diehl, Michael R. Grever, John C. Byrd, and Ian W. Flinn. “A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma..” Ann Hematol 85, no. 5 (May 2006): 301–7. https://doi.org/10.1007/s00277-005-0025-9.

PMID
16518606
Full Text

Kasamon, Yvette L., Ian W. Flinn, Michael R. Grever, Louis F. Diehl, Elizabeth Garrett-Mayer, Steven N. Goodman, Margaret S. Lucas, and John C. Byrd. “Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia..” Clin Cancer Res 11, no. 23 (December 1, 2005): 8413–17. https://doi.org/10.1158/1078-0432.CCR-05-1612.

PMID
16322303
Full Text

Matsui, William, B Douglas Smith, Milada Vala, Nikeshia Beal, Carol Ann Huff, Louis F. Diehl, and Richard J. Jones. “Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia..” Br J Haematol 128, no. 6 (March 2005): 853–62. https://doi.org/10.1111/j.1365-2141.2005.05395.x.

PMID
15755292
Full Text

Pages